Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia

Overview of attention for article published in BMC Neuroscience, October 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

news: 1 news outlet

twitter: 4 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 53 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia.

Alzforum, 23 Oct 2015

Luo J, Lee SH, VandeVrede L, Qin Z, Piyankarage S, Tavassoli E, Asghodom RT, Aissa MB, Fà M, Arancio O, Yue L, Pepperberg DR…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.